These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12400585)

  • 1. Nolvadex: cancer warning added to tamoxifen label.
    Nursing; 2002 Oct; 32(10):24. PubMed ID: 12400585
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Aouar Z; Fat BC; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):173-8. PubMed ID: 19135318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
    Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
    Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine carcinosarcoma in association with tamoxifen therapy.
    Oláh KS
    Br J Obstet Gynaecol; 1997 Dec; 104(12):1420. PubMed ID: 9422027
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tamoxifen as a risk factor for endometrial cancer].
    Hardell L
    Lakartidningen; 1990 Apr; 87(15):1240-1. PubMed ID: 2325497
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA, Zeneca Pharmaceuticals warn of increased uterine-cancer risk with tamoxifen treatment.
    Am J Hosp Pharm; 1994 Jun; 51(11):1380-1. PubMed ID: 7942869
    [No Abstract]   [Full Text] [Related]  

  • 7. Does a BRCA mutation plus tamoxifen equal hysterectomy?
    Lu KH; Kauff ND
    Gynecol Oncol; 2007 Jan; 104(1):3-4. PubMed ID: 17222708
    [No Abstract]   [Full Text] [Related]  

  • 8. Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report.
    Soh E; Eleti A; Jimenez-Linan M; Arends MJ; Latimer J; Sala E
    Acta Radiol; 2008 Sep; 49(7):848-51. PubMed ID: 19143068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of uterine malignancies that develop during and following tamoxifen therapy.
    Ferguson SE; Soslow RA; Amsterdam A; Barakat RR
    Gynecol Oncol; 2006 May; 101(2):322-6. PubMed ID: 16352333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
    Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postmenopausal malignant transformation of extragenital endometriosis. A case report].
    Fat BC; Terzibachian JJ; Govyadovskiy A; Grisey A
    Gynecol Obstet Fertil; 2008 Jan; 36(1):51-5. PubMed ID: 18178119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of adenomyomatous polyp of the uterus associated with tamoxifen therapy.
    Takeuchi M; Matsuzaki K; Uehara H; Shimazu H; Nishitani H
    Radiat Med; 2005 Sep; 23(6):432-4. PubMed ID: 16389986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of tamoxifen and uterine sarcoma.
    Wickerham DL; Fisher B; Wolmark N; Bryant J; Costantino J; Bernstein L; Runowicz CD
    J Clin Oncol; 2002 Jun; 20(11):2758-60. PubMed ID: 12039943
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA issues warning about 'new' tamoxifen risk.
    Twombly R
    J Natl Cancer Inst; 2002 Aug; 94(15):1122. PubMed ID: 12165635
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
    Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
    Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
    Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen may increase risk of uterine sarcoma.
    Gottlieb S
    BMJ; 2002 Jul; 325(7354):7. PubMed ID: 12098716
    [No Abstract]   [Full Text] [Related]  

  • 20. Pleomorphic liposarcoma of the uterus: case report and literature review.
    Levine PH; Wei XJ; Gagner JP; Flax H; Mittal K; Blank SV
    Int J Gynecol Pathol; 2003 Oct; 22(4):407-11. PubMed ID: 14501826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.